Early research (Phase 1)Study completedNCT03247790What this trial is testingLasmiditan in Participants With MigraineWho this might be right forMigraine Disorders Eli Lilly and Company 16
Large-scale testing (Phase 3)Study completedNCT00724815What this trial is testingThe Efficacy and Tolerability of NP101 Patch in the Treatment of Acute MigraineWho this might be right forMigraine Disorders NuPathe Inc. 530
Not applicableEnded earlyNCT01680029What this trial is testingPBASE-system Acute Migraine Clinical InvestigationWho this might be right forAcute Migraine Chordate Medical 50
Not applicableEnded earlyNCT05730556What this trial is testingRemote Electrical Neuromodulation for Acute Procedural PainWho this might be right forChronic Migraine Mayo Clinic 80
Large-scale testing (Phase 3)Looking for participantsNCT04743141What this trial is testingLong-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of MigraineWho this might be right forAcute Treatment of Migraine Pfizer 600
Large-scale testing (Phase 3)Study completedNCT01016678What this trial is testingTreximet Early Intervention Adolescent MigraineWho this might be right forMigraine Premiere Research Institute 104
Post-approval studies (Phase 4)Active Not RecruitingNCT06786650What this trial is testingComparision of the Analgesic Effects of Intravenous Ibuprofen and Tenoxicam in Acute Migraine AttackWho this might be right forMigraineAnalgesic AffectEmergency Medicine Haydarpasa Numune Training and Research Hospital 100
Testing effectiveness (Phase 2)Study completedNCT00712725What this trial is testingMK3207 for Treatment of Acute Migraines (3207-005)Who this might be right forMigraine Merck Sharp & Dohme LLC 676
Not applicableStudy completedNCT04129567What this trial is testingTransnasal Therapy for Acute Migraine AttackWho this might be right forMigraine Disorders Johns Hopkins University 51
Large-scale testing (Phase 3)Study completedNCT04940390What this trial is testingA Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of MigraineWho this might be right forMigraineMigraine With AuraMigraine Without Aura Satsuma Pharmaceuticals, Inc. 1,591
Testing effectiveness (Phase 2)Ended earlyNCT00804973What this trial is testingStudy in Participants With Acute Migraines HeadachesWho this might be right forMigraine Headache Eli Lilly and Company 120
Post-approval studies (Phase 4)Study completedNCT00753311What this trial is testingRizatriptan in Acute Treatment of Migraine in Patients With Unilateral Trigeminal-autonomic Symptoms.Who this might be right forMigraine IRCCS San Raffaele 80
Not applicableEnded earlyNCT03263897What this trial is testingFeasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine ReliefWho this might be right forMigraine Caps Research Network 59
Post-approval studies (Phase 4)Looking for participantsNCT06401642What this trial is testingEffectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive MedicationsWho this might be right forMigraine Mayo Clinic 200
Not applicableStudy completedNCT05653986What this trial is testingAn Observational Study to Assess Change in Disease Activity When Ubrogepant Tablets Are Combined With Atogepant Tablets to Treat Migraine in Adult ParticipantsWho this might be right forMigraine AbbVie 391
Large-scale testing (Phase 3)Study completedNCT00385008What this trial is testingTREXIMA and RELPAX Gastric Scintigraphy Inside and Outside a MigraineWho this might be right forMigraine Disorders GlaxoSmithKline 20
Not applicableEnded earlyNCT03821584What this trial is testingBrain Perfusion Assessment in the Acute Phase of Migraine AuraWho this might be right forEmergencies Nantes University Hospital 25
Large-scale testing (Phase 3)Study completedNCT00382993What this trial is testingCombination Product (Sumatriptan Succinate and Naproxen Sodium) in Migraine Subjects Who Report Poor Response or Intolerance to Short Acting Triptans (Study 2 of 2)Who this might be right forMigraine Disorders GlaxoSmithKline 169
Large-scale testing (Phase 3)Study completedNCT01989936What this trial is testingEletriptan for the Treatment of Migraine in Patients With Previous Poor Response or Tolerance to Oral SumatriptanWho this might be right forMigraine With or Without Aura Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 446
Large-scale testing (Phase 3)Study completedNCT04384367What this trial is testingEfficacy and Safety of Rizatriptan-Naproxen (10/550 Mg) in the Acute Treatment of MigraineWho this might be right forMigraine Eurofarma Laboratorios S.A. 2,068